JP Patent

JP7839162B2 — パルミチン酸パリペリドン製剤の再懸濁を確実にする方法

Assigned to ヤンセン ファーマシューティカ エヌ．ベー． · Expires 2026-04-01 · 0y expired

What this patent protects

Patent listed against Invega Sustenna.

Drugs covered by this patent

Patent Metadata

Patent number
JP7839162B2
Jurisdiction
JP
Classification
—
Expires
2026-04-01
Drug substance claim
No
Drug product claim
No
Assignee
ヤンセン ファーマシューティカ エヌ．ベー．
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.